Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
32.76
+0.36 (1.11%)
At close: Feb 6, 2026, 4:00 PM EST
33.40
+0.64 (1.95%)
After-hours: Feb 6, 2026, 7:49 PM EST
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $955.93 million as of February 6, 2026. Its market cap has increased by 28.80% in one year.
Market Cap
955.93M
Enterprise Value
705.53M
1-Year Change
28.80%
Ranking
Category
Stock Price
$32.76
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $955.93M, an increase of 676.86%. That is a compound annual growth rate of 36.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 955.93M | -15.81% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.86B |
| GeneDx Holdings | 2.44B |
| Neogen | 2.35B |
| NeoGenomics | 1.48B |
| CareDx | 1.00B |
| OPKO Health | 951.95M |
| Fulgent Genetics | 724.59M |
| Personalis | 715.32M |